Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
318.7500
-10.65
(
-3.23
%)
NSE
Sep 15, 2026
12:39 PM
New 52W High in past week
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
06 Jun 2022
318.75
-3.23%
Marksans Pharma
Buy:
Marksans Pharma Ltd.
by
Arihant Capital
Target: 80
Target
Arihant Capital
Axis Direct released a Buy report for Marksans Pharma Ltd. with a price target of 362.0 on 31 Aug, 2026.
More from Marksans Pharma Ltd.
Recommended
Market trades lower, HDFC Bank submits two names for CEO succession to RBI
Trendlyne Marketwatch |
15 Sep 2026, 12:28PM
Five Interesting Stocks Today - September 11, 2026
The Baseline |
11 Sep 2026
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017